TDNA

T. Rowe Price Biotech ETF

23.22

Oct 13 • 2:51 PM ET -0.66 (-2.75%)

Financial Exchange Traded Fund USA NASD

Category	US Equities - Industry Sector
Sponsor	T. Rowe Price
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	0.55%
Inverse/Leveraged
IPO	Sep 17, 2026

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / Yes

Tags	U.S.
Tags	equity
Tags	healthcare
Tags	biotechnology
Tags	pharmaceutical
Tags	innovation
Tags	fundamental
Sector/Theme
Region
SMA20	-5.51%
SMA50	-5.51%
SMA200	-5.51%

Return% 1Y	-
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	0.00%
Flows% 3M	0.00%
Flows% YTD	0.00%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	87
AUM	9.55M
NAV/sh
52W High	25.68 -9.58%
52W Low	23.01 0.91%
Volatility	0.96% -
ATR (14)	0.44
RSI (14)	32.30
Beta	-
Rel Volume	0.18
Avg Volume	2.25K
Volume	347

Perf Week	-3.29%
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	-9.44%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	23.88
Price	23.22
Change %	-2.75%

Sep-17-26 09:58AM

T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS

(PR Newswire)

T. Rowe Price Biotech ETF provides targeted, research-driven active exposure to global biotechnology companies across all market capitalizations that develop and commercialize novel therapies to treat disease. The strategy relies on fundamental bottom-up analysis, leveraging active portfolio management to adjust holdings in response to clinical trials, regulatory approvals, and evolving corporate risk profiles.

open in yahoo | open in marketwatch | open in google

TDNA

T. Rowe Price Biotech ETF

Upgrade your Finviz experience